The expression level of MT1JP was shown to be significantly lower in gastric cancer [43], hepatocellular carcinoma [44] and lung cancer [45] tissues (especially for lymph node metastasis and advanced-stage cancer) than that in adjacent normal tissues. Here, MT1JP is linked to hepatocellular carcinoma.